Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C - Summary - MDSpire

Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C

  • By

  • Benedikt Strunz

  • Qiuyao Zhan

  • Tanvi Khera

  • Julia Hengst

  • Marija Jankovic

  • Katja Deterding

  • Annika Niehrs

  • Markus Cornberg

  • Cheng-Jian Xu

  • Heiner Wedemeyer

  • Niklas K Björkström

  • the HepNet Acute HCV IV Study Group

  • Christoph D Spinner

  • Eckart Schott

  • Tania M Welzel

  • Guido Gerken

  • Hartwig Klinker

  • Ulrich Spengler

  • Johannes Wiegand

  • Julian Schulze zur Wiesch

  • Anita Pathil

  • Andreas Umgelter

  • Caroline Zöllner

  • Stefan Zeuzem

  • Armin Papkalla

  • Kristina Weber

  • Svenja Hardtke

  • Heiko von der Leyen

  • Armin Koch

  • Dorothee von Witzendorff

  • Michael P Manns

  • Kerstin Port

  • Bernhard Schlevogt

  • Marc Ringelhan

  • Ulrich Mayr

  • Judith Schrewe

  • Katharina Sosnowsky

  • Christoph Jochum

  • Gudrun Hilgard

  • Petra Schulze

  • Susanne Wiebecke

  • Ji-Eun Lee

  • Peter Hoffmann

  • December 29, 2025

  • 0 min

Share

Objective:

To assess the NK cell compartment in patients with acute hepatitis C, focusing on functional differences compared to healthy controls and chronic HCV patients.

Key Findings:
  • A subset of highly activated NK cells with a robust type I interferon imprint was identified during acute HCV infection, indicating a significant role in the antiviral response.
  • Activated NK cells normalized after DAA-mediated viral clearance, suggesting reversibility of activation.
  • Long-term phenotypic changes in NK cells were observed in patients post-infection compared to healthy controls, highlighting potential implications for chronic infection.
Interpretation:

The study suggests that type I interferon drives the activation of NK cells during acute hepatitis C, which is reversible upon viral clearance, emphasizing the therapeutic potential of targeting NK cell responses.

Limitations:
  • The study's sample size was limited to 15 patients with acute HCV, which may affect the generalizability of the findings.
  • Longitudinal effects beyond the immediate post-treatment period were not fully explored, leaving gaps in understanding long-term NK cell dynamics.
Conclusion:

The findings provide insights into the immunological mechanisms underlying the antiviral response in acute hepatitis C, highlighting the critical role of NK cells in treatment outcomes.

Original Source(s)

Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C

  • by Benedikt Strunz, Qiuyao Zhan, Tanvi Khera, Julia Hengst, Marija Jankovic, Katja Deterding, Annika Niehrs, Markus Cornberg, Cheng-Jian Xu, Heiner Wedemeyer, Niklas K Björkström, the HepNet Acute HCV IV Study Group, Christoph D Spinner, Eckart Schott, Tania M Welzel, Guido Gerken, Hartwig Klinker, Ulrich Spengler, Johannes Wiegand, Julian Schulze zur Wiesch, Anita Pathil, Andreas Umgelter, Caroline Zöllner, Stefan Zeuzem, Armin Papkalla, Kristina Weber, Svenja Hardtke, Heiko von der Leyen, Armin Koch, Dorothee von Witzendorff, Michael P Manns, Kerstin Port, Bernhard Schlevogt, Marc Ringelhan, Ulrich Mayr, Judith Schrewe, Katharina Sosnowsky, Christoph Jochum, Gudrun Hilgard, Petra Schulze, Susanne Wiebecke, Ji-Eun Lee, Peter Hoffmann

  • December 29, 2025

Related Content

Re: Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018-2023

Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject Drugs

Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents